Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Author Correction: The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD.

Soderborg TK, Clark SE, Mulligan CE, Janssen RC, Babcock L, Ir D, Young B, Kriebs NF, Lemas DJ, Johnson LK, Weir T, Lenz LL, Frank DN, Hernandez TL, Kuhn KA, D'Alessandro A, Barbour LA, El Kasmi KC, Friedman JE.

Nat Commun. 2019 Jul 1;10(1):2965. doi: 10.1038/s41467-019-10943-1.

2.

The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD.

Soderborg TK, Clark SE, Mulligan CE, Janssen RC, Babcock L, Ir D, Young B, Kriebs N, Lemas DJ, Johnson LK, Weir T, Lenz LL, Frank DN, Hernandez TL, Kuhn KA, D'Alessandro A, Barbour LA, El Kasmi KC, Friedman JE.

Nat Commun. 2018 Oct 26;9(1):4462. doi: 10.1038/s41467-018-06929-0. Erratum in: Nat Commun. 2019 Jul 1;10(1):2965.

3.

Editorial overview: Tuning the innate immune response to pathogens.

Alper S, Lenz LL.

Curr Opin Immunol. 2018 Oct;54:vi-ix. doi: 10.1016/j.coi.2018.10.001. No abstract available.

PMID:
30342707
4.

Crosstalk between type I and II interferons in regulation of myeloid cell responses during bacterial infection.

Crisler WJ, Lenz LL.

Curr Opin Immunol. 2018 Oct;54:35-41. doi: 10.1016/j.coi.2018.05.014. Epub 2018 Jun 7. Review.

PMID:
29886270
5.

A Batf3/Nlrp3/IL-18 Axis Promotes Natural Killer Cell IL-10 Production during Listeria monocytogenes Infection.

Clark SE, Schmidt RL, McDermott DS, Lenz LL.

Cell Rep. 2018 May 29;23(9):2582-2594. doi: 10.1016/j.celrep.2018.04.106.

6.

A Listeria-derived polypeptide promotes in vivo activation of NK cells for antitumor therapy.

Ortiz AL, Lenz LL.

Immunohorizons. 2017 Jun 1;1(4):53-62. doi: 10.4049/immunohorizons.1700013. Epub 2017 Jun 26.

7.

Down regulation of macrophage IFNGR1 exacerbates systemic L. monocytogenes infection.

Eshleman EM, Delgado C, Kearney SJ, Friedman RS, Lenz LL.

PLoS Pathog. 2017 May 22;13(5):e1006388. doi: 10.1371/journal.ppat.1006388. eCollection 2017 May.

8.

Altered Natural Killer Cell Function in HIV-Exposed Uninfected Infants.

Smith C, Jalbert E, de Almeida V, Canniff J, Lenz LL, Mussi-Pinhata MM, Cohen RA, Yu Q, Amaral FR, Pinto J, Alarcon JO, Siberry G, Weinberg A.

Front Immunol. 2017 Apr 24;8:470. doi: 10.3389/fimmu.2017.00470. eCollection 2017.

9.

Bacterial Manipulation of NK Cell Regulatory Activity Increases Susceptibility to Listeria monocytogenes Infection.

Clark SE, Filak HC, Guthrie BS, Schmidt RL, Jamieson A, Merkel P, Knight V, Cole CM, Raulet DH, Lenz LL.

PLoS Pathog. 2016 Jun 13;12(6):e1005708. doi: 10.1371/journal.ppat.1005708. eCollection 2016 Jun.

10.

A Breakthrough: Macrophage-Directed Cancer Immunotherapy.

Mills CD, Lenz LL, Harris RA.

Cancer Res. 2016 Feb 1;76(3):513-6. doi: 10.1158/0008-5472.CAN-15-1737. Epub 2016 Jan 15. Review.

11.

Macrophages at the fork in the road to health or disease.

Mills CD, Lenz LL, Ley K.

Front Immunol. 2015 Feb 16;6:59. doi: 10.3389/fimmu.2015.00059. eCollection 2015. No abstract available.

12.

Macrophage: SHIP of Immunity.

Mills CD, Thomas AC, Lenz LL, Munder M.

Front Immunol. 2014 Dec 4;5:620. doi: 10.3389/fimmu.2014.00620. eCollection 2014. Review. No abstract available.

13.

General parity between trio and pairwise breeding of laboratory mice in static caging.

Kedl RM, Wysocki LJ, Janssen WJ, Born WK, Rosenbaum MD, Granowski J, Kench JA, Fong DL, Switzer LA, Cruse M, Huang H, Jakubzick CV, Kosmider B, Takeda K, Stranova TJ, Klumm RC, Delgado C, Tummala S, De Langhe S, Cambier J, Haskins K, Lenz LL, Curran-Everett D.

J Immunol. 2014 Nov 15;193(10):4757-60. doi: 10.4049/jimmunol.1402306.

14.

Type I interferons in bacterial infections: taming of myeloid cells and possible implications for autoimmunity.

Eshleman EM, Lenz LL.

Front Immunol. 2014 Sep 11;5:431. doi: 10.3389/fimmu.2014.00431. eCollection 2014. Review.

15.

Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibody.

Czaja CA, Merkel PA, Chan ED, Lenz LL, Wolf ML, Alam R, Frankel SK, Fischer A, Gogate S, Perez-Velez CM, Knight V.

Clin Infect Dis. 2014 Mar;58(6):e115-8. doi: 10.1093/cid/cit809. Epub 2013 Dec 11.

16.

Type I IFNs downregulate myeloid cell IFN-γ receptor by inducing recruitment of an early growth response 3/NGFI-A binding protein 1 complex that silences ifngr1 transcription.

Kearney SJ, Delgado C, Eshleman EM, Hill KK, O'Connor BP, Lenz LL.

J Immunol. 2013 Sep 15;191(6):3384-92. doi: 10.4049/jimmunol.1203510. Epub 2013 Aug 9.

17.

Distinct licensing of IL-18 and IL-1β secretion in response to NLRP3 inflammasome activation.

Schmidt RL, Lenz LL.

PLoS One. 2012;7(9):e45186. doi: 10.1371/journal.pone.0045186. Epub 2012 Sep 18.

18.

Differential effects of type I and II interferons on myeloid cells and resistance to intracellular bacterial infections.

Kearney S, Delgado C, Lenz LL.

Immunol Res. 2013 Mar;55(1-3):187-200. doi: 10.1007/s12026-012-8362-y. Review.

19.

Early events regulating immunity and pathogenesis during Listeria monocytogenes infection.

Williams MA, Schmidt RL, Lenz LL.

Trends Immunol. 2012 Oct;33(10):488-95. doi: 10.1016/j.it.2012.04.007. Epub 2012 Jun 5. Review.

20.

Nitric oxide increases susceptibility of Toll-like receptor-activated macrophages to spreading Listeria monocytogenes.

Cole C, Thomas S, Filak H, Henson PM, Lenz LL.

Immunity. 2012 May 25;36(5):807-20. doi: 10.1016/j.immuni.2012.03.011. Epub 2012 Apr 26. Erratum in: Immunity. 2012 May 25;36(5):885.

21.

Lung B cells promote early pathogen dissemination and hasten death from inhalation anthrax.

Rayamajhi M, Delgado C, Condon TV, Riches DW, Lenz LL.

Mucosal Immunol. 2012 Jul;5(4):444-54. doi: 10.1038/mi.2012.21. Epub 2012 Apr 4.

22.

A LysM and SH3-domain containing region of the Listeria monocytogenes p60 protein stimulates accessory cells to promote activation of host NK cells.

Schmidt RL, Filak HC, Lemon JD, Potter TA, Lenz LL.

PLoS Pathog. 2011 Nov;7(11):e1002368. doi: 10.1371/journal.ppat.1002368. Epub 2011 Nov 3.

23.

MPYS is required for IFN response factor 3 activation and type I IFN production in the response of cultured phagocytes to bacterial second messengers cyclic-di-AMP and cyclic-di-GMP.

Jin L, Hill KK, Filak H, Mogan J, Knowles H, Zhang B, Perraud AL, Cambier JC, Lenz LL.

J Immunol. 2011 Sep 1;187(5):2595-601. doi: 10.4049/jimmunol.1100088. Epub 2011 Aug 3.

24.

Transient Receptor Potential Melastatin 2 (TRPM2) ion channel is required for innate immunity against Listeria monocytogenes.

Knowles H, Heizer JW, Li Y, Chapman K, Ogden CA, Andreasen K, Shapland E, Kucera G, Mogan J, Humann J, Lenz LL, Morrison AD, Perraud AL.

Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11578-83. doi: 10.1073/pnas.1010678108. Epub 2011 Jun 27.

25.

Non-surgical intratracheal instillation of mice with analysis of lungs and lung draining lymph nodes by flow cytometry.

Rayamajhi M, Redente EF, Condon TV, Gonzalez-Juarrero M, Riches DW, Lenz LL.

J Vis Exp. 2011 May 2;(51). pii: 2702. doi: 10.3791/2702.

26.

IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cells.

Boudreau JE, Stephenson KB, Wang F, Ashkar AA, Mossman KL, Lenz LL, Rosenthal KL, Bramson JL, Lichty BD, Wan Y.

Cancer Res. 2011 Apr 1;71(7):2497-506. doi: 10.1158/0008-5472.CAN-10-3025. Epub 2011 Feb 9.

27.

Antagonistic crosstalk between type I and II interferons and increased host susceptibility to bacterial infections.

Rayamajhi M, Humann J, Kearney S, Hill KK, Lenz LL.

Virulence. 2010 Sep-Oct;1(5):418-22. doi: 10.4161/viru.1.5.12787. Review.

28.

Cellular reactive oxygen species inhibit MPYS induction of IFNβ.

Jin L, Lenz LL, Cambier JC.

PLoS One. 2010 Dec 10;5(12):e15142. doi: 10.1371/journal.pone.0015142.

29.

Activation of naive NK cells in response to Listeria monocytogenes requires IL-18 and contact with infected dendritic cells.

Humann J, Lenz LL.

J Immunol. 2010 May 1;184(9):5172-8. doi: 10.4049/jimmunol.0903759. Epub 2010 Mar 29.

30.

Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma.

Rayamajhi M, Humann J, Penheiter K, Andreasen K, Lenz LL.

J Exp Med. 2010 Feb 15;207(2):327-37. doi: 10.1084/jem.20091746. Epub 2010 Feb 1.

31.

Bacterial peptidoglycan degrading enzymes and their impact on host muropeptide detection.

Humann J, Lenz LL.

J Innate Immun. 2009;1(2):88-97. doi: 10.1159/000181181. Review.

32.

CD5 sweetens lymphocyte responses.

Lenz LL.

Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1303-4. doi: 10.1073/pnas.0812579106. Epub 2009 Jan 27. No abstract available.

33.

Stable integration vector for nutrient broth-based selection of attenuated Listeria monocytogenes strains with recombinant antigen expression.

Lenz LL, Huang WA, Zhou C, Li Z, Calendar R.

Clin Vaccine Immunol. 2008 Sep;15(9):1414-9. doi: 10.1128/CVI.00208-08. Epub 2008 Jul 23.

34.
35.

Activation of cytosolic phospholipase A2alpha in resident peritoneal macrophages by Listeria monocytogenes involves listeriolysin O and TLR2.

Noor S, Goldfine H, Tucker DE, Suram S, Lenz LL, Akira S, Uematsu S, Girotti M, Bonventre JV, Breuel K, Williams DL, Leslie CC.

J Biol Chem. 2008 Feb 22;283(8):4744-55. Epub 2007 Dec 14.

36.
37.

Cytosolic expression of SecA2 is a prerequisite for long-term protective immunity.

Muraille E, Narni-Mancinelli E, Gounon P, Bassand D, Glaichenhaus N, Lenz LL, Lauvau G.

Cell Microbiol. 2007 Jun;9(6):1445-54. Epub 2007 Jan 23.

PMID:
17244189
38.

TRAIL-R as a negative regulator of innate immune cell responses.

Diehl GE, Yue HH, Hsieh K, Kuang AA, Ho M, Morici LA, Lenz LL, Cado D, Riley LW, Winoto A.

Immunity. 2004 Dec;21(6):877-89.

39.

Promiscuity of MHC class Ib-restricted T cell responses.

Ploss A, Lauvau G, Contos B, Kerksiek KM, Guirnalda PD, Leiner I, Lenz LL, Bevan MJ, Pamer EG.

J Immunol. 2003 Dec 1;171(11):5948-55.

40.

SecA2-dependent secretion of autolytic enzymes promotes Listeria monocytogenes pathogenesis.

Lenz LL, Mohammadi S, Geissler A, Portnoy DA.

Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12432-7. Epub 2003 Oct 3.

41.
44.

H2-M3 restricted presentation of a Listeria-derived leader peptide.

Princiotta MF, Lenz LL, Bevan MJ, Staerz UD.

J Exp Med. 1998 May 18;187(10):1711-9.

45.

CTL responses to H2-M3-restricted Listeria epitopes.

Lenz LL, Bevan MJ.

Immunol Rev. 1997 Aug;158:115-21. Review.

PMID:
9314079
46.

Primary and secondary immune responses to Listeria monocytogenes.

Harty JT, Lenz LL, Bevan MJ.

Curr Opin Immunol. 1996 Aug;8(4):526-30. Review.

47.
48.

H2-M3 restricted presentation of Listeria monocytogenes antigens.

Lenz LL, Bevan MJ.

Immunol Rev. 1996 Jun;151:107-21. Review. No abstract available.

PMID:
8872487
49.

[Prostatitis].

Lenz LL.

AMB Rev Assoc Med Bras. 1990 Jan-Mar;36(1):21-5. Review. Portuguese. No abstract available.

PMID:
1962876
50.

[General practice & cosmetic surgery].

LENZ LL.

Medizinische. 1959 Mar 7;4(10):426-8. German. No abstract available.

PMID:
13643493

Supplemental Content

Support Center